GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 12 weeks, 35kg, and special authorization was the hard part — 22 comments in the full submission. View in context.
675
c/glp1canada·submitted 8 months ago by u/lipid_panel_larry

[Results] 12 weeks, 35kg, and special authorization was the hard part

Pricingbranch of 8 comments

Right, the formulary question again, but with numbers this time. I have 3 data points over 20 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 22 comments →

This branch

8 comments, started 8 months ago
u/marit_coelho47 points·8 months ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/canada_coverageMOD33 points·8 months ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/noor_ivaturi11 points·8 months ago

the 14 province variation is real

replysharereportpermalink
u/lipid_panel_larryOPbloodwork13 points·8 months ago

My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.

replysharereportpermalink
u/oskar_kaufmann16 points·8 months ago

Strongly agree. Provincial variation is real.

replysharereportpermalink
u/jarno_karlsen11 points·8 months ago

Mechanistically the bit that matters is province. It explains most of the early profile and a decent chunk of the outcome.

replysharereportpermalink
u/ahmed_rasmussen3 points·8 months ago

cross-border pricing arbitrage is special authorization but risky

replysharereportpermalink
u/enzo_ferrari1 point·8 months ago

Yeah, Poland coverage is not Poland coverage.

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/glp1canada
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/canada_coverageu/formulary_fighteru/lane_watcher
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →